Joe Wiley, CEO of Amryt Pharma discusses their $40m Private Placement with Leading Biotech Investors

Episode 92,   Dec 09, 2020, 01:44 PM

Headliner
Share
Subscribe
Joe Wiley, CEO of Amryt Pharma #AMYT discusses their $40m Private Placement with Leading Biotech Investors and how being listed on NASDAQ has increased interest in the company.
Share
Subscribe
Next
Tim Sykes, CEO at Proactis discusses the significance of signing its first bePayd contract
Top episodes
Is a house price crash coming?
by The Vox Markets Podcast
Alastair Smith of Avacta: Successful Completion of Fourth Dose Escalation in AVA6000 Study
by The Vox Markets Podcast
Vox Markets Interview with Avacta CEO Alastair Smith
by The Vox Markets Podcast
Related episodes
Paul Hill on what he expects for the markets in 2022 and some Stocks to Follow
by The Vox Markets Podcast
Paul Hill on when will the negative sentiment turn? Plus Stocks to Follow
by The Vox Markets Podcast
Paul Hill discusses whether the fear is priced in and some stocks to follow
by The Vox Markets Podcast